Our previous study demonstrated that BRD7 expression is significantly associated with a favorable prognosis in HCC patients and is involved in impeding tumor development by inhibiting proliferation, cell cycle progression, and cellular migration/invasion 12. The gene discussed is BRD7; the disease is neoplasm.